RU2010113510A - Способы рекомбинантной продукции антител против респираторно-цинцитиального вируса (rsv) - Google Patents

Способы рекомбинантной продукции антител против респираторно-цинцитиального вируса (rsv) Download PDF

Info

Publication number
RU2010113510A
RU2010113510A RU2010113510/10A RU2010113510A RU2010113510A RU 2010113510 A RU2010113510 A RU 2010113510A RU 2010113510/10 A RU2010113510/10 A RU 2010113510/10A RU 2010113510 A RU2010113510 A RU 2010113510A RU 2010113510 A RU2010113510 A RU 2010113510A
Authority
RU
Russia
Prior art keywords
polyclonal
antibody
antibodies
cell line
group
Prior art date
Application number
RU2010113510/10A
Other languages
English (en)
Russian (ru)
Inventor
Анне Бондгор ТОЛСТРУП (DK)
Анне Бондгор ТОЛСТРУП
Йохан ЛАНТТО (SE)
Йохан ЛАНТТО
Финн ВИБЕРГ (DK)
Финн ВИБЕРГ
Ларс Согор НИЛЬСЕН (DK)
Ларс Согор НИЛЬСЕН
Original Assignee
Симфоген А/С (Dk)
Симфоген А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Симфоген А/С (Dk), Симфоген А/С filed Critical Симфоген А/С (Dk)
Publication of RU2010113510A publication Critical patent/RU2010113510A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/11—Paramyxoviridae (F); Pneumoviridae (F), e.g. respiratory syncytial virus [RSV]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RU2010113510/10A 2007-09-07 2008-09-04 Способы рекомбинантной продукции антител против респираторно-цинцитиального вируса (rsv) RU2010113510A (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200701289 2007-09-07
DKPA200701289 2007-09-07
US97140407P 2007-09-11 2007-09-11
US60/971,404 2007-09-11

Publications (1)

Publication Number Publication Date
RU2010113510A true RU2010113510A (ru) 2011-10-20

Family

ID=40297785

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010113510/10A RU2010113510A (ru) 2007-09-07 2008-09-04 Способы рекомбинантной продукции антител против респираторно-цинцитиального вируса (rsv)

Country Status (13)

Country Link
US (2) US20090137003A1 (https=)
EP (1) EP2185590A2 (https=)
JP (1) JP2011514139A (https=)
KR (1) KR20100087283A (https=)
CN (1) CN101821289A (https=)
AU (1) AU2008295248A1 (https=)
BR (1) BRPI0817079A2 (https=)
CA (1) CA2695309A1 (https=)
MX (1) MX2010002044A (https=)
RU (1) RU2010113510A (https=)
TW (1) TW200925279A (https=)
WO (1) WO2009030237A2 (https=)
ZA (1) ZA201000756B (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2444695T3 (es) * 2006-06-23 2014-02-26 Alethia Biotherapeutics Inc. Polinucleótidos y polipéptidos implicados en el cáncer
DK2121920T3 (da) * 2007-03-01 2011-11-21 Symphogen As Fremgangsmåde til kloning af sammenhørende antistoffer
EP1997830A1 (en) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV specific binding molecules and means for producing them
CN102137928A (zh) * 2008-08-29 2011-07-27 西福根有限公司 克隆禽源抗体的方法
CA2740900C (en) 2008-11-03 2019-09-24 Alethia Biotherapeutics Inc. Antibodies that specifically block the biological activity of a tumor antigen
GB0905023D0 (en) 2009-03-24 2009-05-06 Univ Erasmus Medical Ct Binding molecules
JP5762408B2 (ja) * 2009-08-13 2015-08-12 クルセル ホランド ベー ヴェー ヒト呼吸器合胞体ウイルス（ｒｓｖ）に対する抗体および使用方法
EP2486053B1 (en) * 2009-10-06 2017-01-18 Medimmune Limited Rsv-specific binding molecule
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
CN104628850B (zh) * 2009-10-06 2020-07-28 医学免疫有限公司 Rsv-特异性结合分子
ES2724975T3 (es) 2009-12-10 2019-09-18 Regeneron Pharma Ratones que producen anticuerpos de cadena pesada
BR112012031638B1 (pt) 2010-07-09 2021-01-12 Janssen Vaccines & Prevention B.V. anticorpo anti-rsv ou fragmento de ligação de antígeno do mesmo, anticorpo multivalente, composição farmacêutica, uso de anticorpo ou fragmento de ligação de antígeno, método de detectar infecção por rsv, e, ácido nucleico isolado
SI3173427T1 (sl) 2011-03-31 2019-08-30 ADC Therapeutics SA, Protitelesa proti antigenu 1, povezanemu z ledvicami, in antigen vezavni fragmenti le-tega
KR102102239B1 (ko) 2012-01-09 2020-04-21 에이디씨 테라퓨틱스 에스에이 유방암을 치료하기 위한 방법
TWI606063B (zh) * 2012-08-23 2017-11-21 艾澤西公司 結合至１５８ｐ１ｄ７蛋白之抗體藥物結合物（ａｄｃ）
JP5996707B2 (ja) * 2015-04-15 2016-09-21 メディミューン リミテド Ｒｓｖ特異的結合分子
SG11201708804WA (en) 2015-05-07 2017-11-29 Agenus Inc Anti-ox40 antibodies and methods of use thereof
MA43389A (fr) * 2015-12-02 2021-05-12 Agenus Inc Anticorps anti-ox40 et leurs procédés d'utilisation
AU2016364891A1 (en) * 2015-12-03 2018-06-07 Agenus Inc. Anti-OX40 antibodies and methods of use thereof
CN110035771B (zh) * 2016-10-21 2024-03-08 阿迪马布有限责任公司 抗呼吸道合胞病毒抗体及其产生和使用方法
AU2017345786B2 (en) 2016-10-21 2024-08-01 Adimab, Llc Anti-respiratory syncytial virus antibodies, and methods of their generation and use
US11479600B2 (en) 2016-10-21 2022-10-25 Adimab, Llc Anti-respiratory syncytial virus antibodies, and methods of their generation and use
MA46770A (fr) 2016-11-09 2019-09-18 Agenus Inc Anticorps anti-ox40, anticorps anti-gitr, et leurs procédés d'utilisation
WO2018150029A1 (en) * 2017-02-17 2018-08-23 Institut Pasteur Generation of monoclonal antibodies targeting respiratory syncytial virus (rsv) using regulatory b cells from newborns (nbregs)
CN113728003A (zh) 2019-04-30 2021-11-30 吉加根公司 重组多克隆蛋白及其使用方法
WO2021202463A1 (en) 2020-03-30 2021-10-07 Danisco Us Inc Anti-rsv antibodies
WO2021253002A1 (en) 2020-06-12 2021-12-16 Gigagen, Inc. Recombinant polyclonal proteins targeting covid-19 and methods of use thereof
WO2022031834A1 (en) * 2020-08-05 2022-02-10 Gigagen, Inc. Recombinant polyclonal proteins targeting zika and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060275766A1 (en) * 2003-01-07 2006-12-07 Haurum John S Method for manufacturing recombinant polyclonal proteins
TWI333977B (en) * 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
US8288109B2 (en) * 2004-07-20 2012-10-16 Symphogen A/S Procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
EA014182B1 (ru) * 2004-07-20 2010-10-29 Симфоген А/С КОМПОЗИЦИЯ ПОЛИКЛОНАЛЬНЫХ АНТИ-RhD АНТИТЕЛ, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ КОМПОЗИЦИИ
US7850965B2 (en) * 2005-12-05 2010-12-14 Symphogen A/S Anti-orthopoxvirus recombinant polyclonal antibody
WO2007101441A1 (en) * 2006-03-06 2007-09-13 Symphogen A/S Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
JP2010534057A (ja) * 2007-03-06 2010-11-04 シムフォゲン・アクティーゼルスカブ 呼吸器合胞体ウイルス感染症を治療するための組換え抗体
MX2009012526A (es) * 2007-05-25 2009-12-09 Symphogen As Metodo para fabricar una proteina policlonal recombinante.

Also Published As

Publication number Publication date
CN101821289A (zh) 2010-09-01
BRPI0817079A2 (pt) 2016-10-11
CA2695309A1 (en) 2009-03-12
US20090137003A1 (en) 2009-05-28
WO2009030237A2 (en) 2009-03-12
AU2008295248A1 (en) 2009-03-12
ZA201000756B (en) 2010-10-27
JP2011514139A (ja) 2011-05-06
EP2185590A2 (en) 2010-05-19
WO2009030237A3 (en) 2009-04-30
KR20100087283A (ko) 2010-08-04
TW200925279A (en) 2009-06-16
MX2010002044A (es) 2010-03-18
US20120009623A1 (en) 2012-01-12

Similar Documents

Publication Publication Date Title
RU2010113510A (ru) Способы рекомбинантной продукции антител против респираторно-цинцитиального вируса (rsv)
JP2019031529A5 (https=)
US8399249B2 (en) Procedure for the generation of a high producer cell line for the expression of a recombinant anti-CD34 antibody
US9708389B2 (en) Method for preparing homodimer protein mixture by using charge repulsion effect
RU2013111533A (ru) Способы получения мультиспецифичных и мультивалентных антител
Kwakkenbos et al. Genetic manipulation of B cells for the isolation of rare therapeutic antibodies from the human repertoire
JP2011514139A5 (https=)
JP2022033734A (ja) グルタミンシンセターゼ遺伝子内相補ベクターを用いた高レベルのヘテロマータンパク質発現細胞の直接選択
HRP20100640T1 (hr) Postupak proizvodnje rekombinantnog poliklonskog proteina
CN102282266A (zh) 高复杂度哺乳动物展示文库及其筛选方法
US11821001B2 (en) Cell culture medium for eukaryotic cells
AU2025204213A1 (en) Antigen binding regions against fibronectin type III domains and methods of using the same
Bowers et al. Humanization of antibodies using heavy chain complementarity-determining region 3 grafting coupled with in vitro somatic hypermutation
RU2010122044A (ru) УЛУЧШЕННЫЕ МОЛЕКУЛЫ, СВЯЗЫВАЮЩИЕСЯ С Nogo-А И ИХ ФАРМАЦЕВТИЧЕСКОЕ ПРИМЕНЕНИЕ
Lightwood et al. Antibody generation through B cell panning on antigen followed by in situ culture and direct RT-PCR on cells harvested en masse from antigen-positive wells
WO2020119663A1 (zh) 抗h7n9全人源单克隆抗体4e18及其制法与应用
MXPA04002489A (es) Seleccion de celulas que expresan polipeptidos heteromericos.
CN114539403A (zh) 靶向人bcma蛋白的兔重组单克隆抗体及应用
WO2020119666A1 (zh) 抗h7n9全人源单克隆抗体3f12及其制法与应用
CA2331917A1 (en) Novel method for gene cloning
CN119978129B (zh) 一种抗kofu dna聚合酶的抗体及其应用
JP7794605B2 (ja) 抗体の製造方法及び抗体
CN102686730A (zh) 重组抗体载体
US20220243222A1 (en) Vectors and expression systems for producing recombinant proteins
Yamashita et al. Effect of novel monoclonal antibodies on LIF-induced signaling in chicken blastodermal cells

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20120918